Advance on chemokines in organ-specific metastasis of non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 12, Issue 10, 2009, Pages 1110-1114

  Chen, Gang ^a   Wang, Zhou ^a   Liu, Xiangyan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CX3C CHEMOKINE; EOTAXIN 3; FRACTALKINE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

CANCER GROWTH; LUNG NON SMALL CELL CANCER; METASTASIS; PEYER PATCH; SHORT SURVEY;

EID: 75449095290     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.10.11     Document Type: Short Survey

References (50)

1. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410(6824): 50-56.
2. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity, 2000, 12(2): 121-127.
3. Rollins BJ. Chemokines. Blood, 1997, 90(3): 909-928.
4. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol, 2000,18: 217-242.
5. Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol, 2004, 14(3): 181-185.
6. Tanaka T, Bai Z, Srinoulprasert Y, et al. Chemokines in tumor progression and metastasis. Cancer Sci, 2005, 96(6): 317-322.
7. Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol, 2006, 79(4): 639-651.
8. Strieter RM, Belperio JA, Phillips RJ, et al. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol, 2004, 14(3): 195-200.
9. Singh S, Sadanandam A, Singh RK. Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev, 2007, 26(3-4): 453-467.
10. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood, 2006, 107(5): 1761-1767.
11. Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol, 2004, 35(3): 233-245.
12. Crump MP, Gong JH, Loetscher P, et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J, 1997, 16(23): 6996-7007.
13. Lataillade JJ, Domenech J, Le Bousse-Kerdilès MC. Stromal cell-derived factor-1 (SDF-1)\CXCR4 couple plays multiple roles on haematopoietic progenitors at the border between the old cytokine and new chemokine worlds: survival, cell cycling and trafficking. Eur Cytokine Netw, 2004, 15(3): 177-188.
14. Strieter RM, Belperio JA, Phillips RJ, et al. Chemokines: angiogenesis and metastases in lung cancer. Novartis Found Symp, 2004, 256: 173-184.
15. Saur D, Seidler B, Schneider G, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology, 2005, 129(4): 1237-1250.
16. Lee HJ, Kim SW, Kim HY, et al. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol, 2009, 34(2): 473-480.
17. Schimanski CC, Bahre R, Gockel I, et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer, 2006, 95(2): 210-217.
18. Kim J, Mori T, Chen SL, et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg, 2006, 244(1): 113-120.
19. Sasaki K, Natsugoe S, Ishigami S, et al. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Oncol Rep, 2009, 21(1): 65-71.
20. Akashi T, Koizumi K, Tsuneyama K, et al. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci, 2008, 99(3): 539-542.
21. Kajiyama H, Shibata K, Terauchi M, et al. Involvement of SDF-1alpha/ CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer, 2008, 122(1): 91-99.
22. Gassmann P, Haier J, Schlüter K, et al. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia, 2009, 11(7): 651-661.
23. Uchida D, Onoue T, Tomizuka Y, et al. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res, 2007, 5(7): 685-694.
24. Phillips RJ, Burdick MD, Lutz M, et al. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med, 2003, 167(12): 1676-1686.
25. Su LP, Zhang JP, Xu HB, et al. "e role of CXCR4 in lung cancer metastasis and its possible mechanism. Natl Med J China, 2005, 85(17): 1190-1194. CXCR4, 2005, 85(17): 1190-1194.]
26. Su LP, Zhang JP, Zheng XJ, et al. The Effect of the Expression Level of CXCR4 on the Metastatic Potential of Human Lung Cancer Cells. Chin J Cancer Biother, 2005, 12(1): 46-51. CXCR4, 2005, 12(1): 46-51.]
27. Wagner PL, Hyjek E, Vazquez MF, et al. CXCL12 and CXCR4 in adeno-carcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg, 2009, 137(3): 615-621.
28. Nagira M, Imai T, Hieshima K, et al. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoat-tractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem, 1997, 272(31): 19518-19524.
29. Yoshida R, Nagira M, Kitaura M, et al. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem, 1998, 273(12): 7118-7122.
30. Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol, 2008, 8(5): 362-371.
31. Sánchez-Sánchez N, Riol-Blanco L, Rodríguez- Fernández JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol, 2006, 176(9): 5153-5159.
32. Hirao M, Onai N, Hiroishi K, et al. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res, 2000, 60(8): 2209-2217.
33. Sharma S, Stolina M, Luo J, et al. lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol, 2000, 164(9): 4558-4563.
34. Sharma S, Stolina M, Zhu L, et al. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res, 2001, 61(17): 6406-6412.
35. Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res, 2002, 62(10): 2937-2941.
36. Takeuchi H, Fujimoto A, Tanaka M, et al. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res, 2004, 10(7): 2351-2358.
37. Shang ZJ, Liu K, Shao Z. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma. Oral Oncol, 2009, 45(6): 480-485.
38. Nakata B, Fukunaga S, Noda E, et al. Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology, 2008, 74(1-2): 69-75.
39. Günther K, Leier J, Henning G, et al. Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer, 2005, 116(5): 726-733.
40. Ding Y, Shimada Y, Maeda M, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res, 2003, 9(9): 3406-3412.
41. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer, 2003, 105(2): 186-189.
42. Koizumi K, Kozawa Y, Ohashi Y, et al. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol Rep, 2007, 17(6): 1511-1516.
43. Maekawa S, Iwasaki A, Shirakusa T, et al. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma. Oncol Rep, 2008, 19(6): 1461-1468.
44. Zeng T, Wen JH, Li X. The value and association of CCR7 expression in NSCLC with lymph node metastasis. Chin J Lung Cancer, 2008, 11(2): 246-250. 2008, 11(2): 246-250.]
45. Li Y, Qiu X, Zhang S, et al. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells. Cancer Biol Ther, 2009, 8(4): 322-330.
46. Zhu YM, Webster SJ, Flower D, et al. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer, 2004, 91(11): 1970-1976.
47. Iwakiri S, Mino N, Takahashi T, et al. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I non-small cell lung cancer. Cancer, 2009, 115(11): 2580-2593.
48. Wang CL, Sun BS, Tang Y, et al. CCR1 knockdown suppresses human non-small cell lung cancer cell invasion. J Cancer Res Clin Oncol, 2009, 135(5): 695-701.
49. Homey B, Müller A, Zlotnik A. Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol, 2002, 2(3): 175-184.
50. Richert MM, Vaidya KS, Mills CN, et al. Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone. Oncol Rep, 2009, 21(3): 761-767.